Heping Zhou
Papers
1
Total Citations
384
H-Index
1
About
Heping Zhou has made seminal contributions to cancer biomarker discovery, particularly through innovative proteomic approaches. Her landmark 2003 study on antibody microarray profiling of human prostate cancer sera, which has garnered 384 citations, introduced a practical strategy for serum protein profiling that enabled the simultaneous screening of multiple antibodies and identification of potential biomarkers. By comparing protein abundances across 33 prostate cancer and 20 control serum samples, Zhou demonstrated how antibody microarrays could efficiently distinguish disease states from healthy controls. This work laid critical groundwork for high-throughput proteomic analysis in oncology, establishing a methodological framework that has been widely adopted in cancer research. Zhou's research sits at the intersection of analytical chemistry, immunology, and clinical diagnostics, with her contributions enabling more sensitive and specific detection of cancer biomarkers. Her pioneering use of antibody arrays for serum profiling has influenced subsequent studies in prostate cancer and other malignancies, helping to advance the field toward more effective, non-invasive diagnostic tools.
Research Focus
Key Achievements
Top Papers
- 1